Kitchener, Ontario, December 20, 2019 - James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX VENTURE: JWCA; OTCQX: JWCAF), is pleased to announce the initial closing of its non-brokered private placement whereby the Corporation has issued 4,734,284 units of the Corporation (each, a “Unit”) for gross proceeds of $994,199.64 (the “Initial Closing”).

The Initial Closing is part of a larger offering being conducted by the Corporation for up to 35,714,285 Units at a purchase price of $0.21 per Unit, to raise gross proceeds of up to $7,500,000 (the “Offering”). Each Unit is comprised of one common share of the Corporation (a “Common Share”) and one half of one common share purchase warrant (each full warrant, a “Warrant”). Each Warrant will be exercisable to purchase one Common Share at an exercise price of $0.275 per share for a period of three (3) years following the date of issuance. The securities underlying the Units will all be subject to a four-month statutory hold period commencing on the date of issuance.

Certain directors, officers and other insiders of the Corporation participated in the Initial Closing for a total of $239,999.76 worth of Units. Participation by those persons constitutes a related party transaction as defined under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The issuance of Units to the related parties is exempt from the formal valuation requirements of Section 5.4 of MI 61-101 pursuant to Subsection 5.5(a) of MI 61-101 and exempt from the minority shareholder approval requirements of Section 5.6 of MI 61-101 pursuant to Subsection 5.7(1)(a) of MI 61-101.

The Corporation intends to use the proceeds of the Offering for corporate and general working capital purposes and to further develop the Corporation’s second facility located at 530 Manitou Drive, Kitchener, Ontario.

The Offering is scheduled to close in tranches, with the final closing expected to take place on or about January 10, 2020. Closing of each tranche of the Offering is subject to customary closing conditions, including, without limitation, receipt of applicable regulatory approvals, including the approval of the TSX Venture Exchange.

Nathan Woodworth, President and Chief Executive Officer of JWC, said: “The current financing will allow us to strengthen our balance sheet at a critical point in the history of our industry, allowing us to move forward in confidence into the new year. It also gives us the opportunity to strengthen ties with existing investors while forming relationships with new investors.”

About James E. Wagner Cultivation Corporation

James E. Wagner Cultivation Corporation’s wholly owned subsidiary is a Licensed Producer under the Cannabis Regulations, formerly the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis using an advanced and proprietary aeroponic platform named GrowthSTORM™. JWC began as a collective of patients and growers under the Marihuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC is a family-run, family-owned company with deep roots planted in the local community. JWC’s operations are based in Kitchener, Ontario. Learn more at

For additional information about JWC, please refer to JWC’s profile on SEDAR ( or the Corporation’s website:

Notice Regarding Forward-Looking Statements

This press release contains statements including forward-looking information for purposes of applicable securities laws (“forward-looking statements”) about JWC and its business and operations which include statements regarding the launch of the Offering, the terms of the Offering, the issuance of Units of the Corporation, the ability of the Corporation to obtain the final approval of the TSX Venture Exchange, the closing of the Offering and the use of proceeds of the Offering. The forward-looking statements can be identified by the use of such words as “will”, “expected”, “approximately”, “may”, “could”, “would” or similar words and phrases. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those implied in the forward-looking statements. For example, risks include risks regarding the cannabis industry, economic factors, the equity markets generally, building permit related risks and risks associated with growth and competition as well as the risks identified in the Corporation’s Filing Statement available under the Corporation’s profile at Although JWC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and are based on current assumptions which management believes to be reasonable. The Corporation disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Company Contact Nathan Woodworth, President & CEO of JWC
Phone: (519) 594-0144 x421


Investor Relations
Jonathan Leuchs, CMA
Phone: (949) 432-7758

Toll Free 1-888-594-4272
Hours Mon - Fri 7:30am - 5pm EST
Fax 1-855-787-3934
PO Box 46015
Kitchener, Ontario
N2E 4J3
Get Connected
Sign up to receive the latest on JWC!
Sign Up
Curious about cannabis? Find answers to your questions and definitions for common industry terms.
Check it out!
©2020 JAMES E. WAGNER CULTIVATION | User Terms of Use